Targeting tumor heterogeneity using an injectable gelatin hydrogel for the dual elimination of cancer cells and cancer stem cells.
Breast cancer relapse and therapeutic resistance recurrence are mainly due to the presence of breast cancer-associated cancer stem cells (bCSCs), which are inadequately eradicated by conventional chemotherapeutic agents. To mitigate these challenges, we engineered an injectable in situ-forming gelatin hydrogel capable...